CHESAPEAKE ASSET MANAGEMENT LLC

Position in PFE — Pfizer Inc

CIK 1079397 NEW YORK, NY

Position in PFE

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$96,512

-$15,021 QoQ

Shares Held

4,008

+0.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#2,547

of 2,820 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHESAPEAKE ASSET MANAGEMENT LLC holds $16,421,292 across 10 Drug Manufacturers - General names. PFE ranks #5 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,659	$11,585,295
2	MRK	Merck & Co., Inc.	15,999	$2,055,871
3	ABBV	AbbVie Inc.	5,763	$1,450,201
4	JNJ	Johnson & Johnson	4,549	$1,155,309
5	PFE	Pfizer Inc This page	4,008	$96,512
6	BMY	Bristol Myers Squibb Co	972	$56,006
7	GSK	GSK plc	248	$13,000
8	AZN	Astrazeneca PLC	37	$7,015

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$96,512	4,008	+0.9%	Shares	Sole	2026-08-04
2026-03-31	$111,533	3,972	-13.1%	Shares	Sole	2026-05-12
2025-12-31	$113,842	4,572	-24.7%	Shares	Sole	2026-01-08
2025-09-30	$154,714	6,072	-14.1%	Shares	Sole	2025-10-17
2025-06-30	$171,425	7,072	+7.4%	Shares	Sole	2025-10-15
2025-03-31	$166,838	6,584	+8.4%	Shares	Sole	2026-01-05
2024-12-31	$161,090	6,072	+68.1%	Shares	Sole	2026-01-05
2024-09-30	$104,531	3,612	+87.9%	Shares	Sole	2026-01-05
2024-06-30	$53,777	1,922	+24.2%	Shares	Sole	2026-01-05
2024-03-31	$42,929	1,547	-59.8%	Shares	Sole	2026-01-05
2023-12-31	$110,755	3,847	-6.3%	Shares	Sole	2026-01-05
2023-09-30	$136,162	4,105	0.0%	Shares	Sole	2026-01-05
2023-06-30	$150,571	4,105	-40.5%	Shares	Sole	2026-01-05
2023-03-31	$281,560	6,901	—	Shares	Sole	2026-01-05
No filing history on record for this holder in this stock.